XBiotech Strengthens Intellectual Property Portfolio for Its True Human(TM) Antibody Technology
AUSTIN, Texas, Oct. 19, 2015 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ:XBIT), the world's leading developer of next-generation True Human™ therapeutic antibodies, announced that it has received a Notice of Allowance from the United States Patent and …